Chromatographia

, Volume 61, Issue 5–6, pp 265–270 | Cite as

Determination of Levodopa and Benserazide Hydrochloride in Pharmaceutical Formulations by CZE with Amperometric Detection

Article

Abstract

A novel method, capillary electrophoresis with amperometric detection, has been established for rapid and effective measurement of levodopa (L-dopa), and benserazide (BS) and its impurity (R,S)-2-amino-3-hydroxypropanohydrazide (Ro-04-1419) in co-beneldopa pharmaceutical formulations. Suitable separation and amperometric detection conditions were investigated and optimized. The optimum conditions of CZE detection were 40 mm phosphate solution at pH 5.3 as running buffer, 17 kV separation voltage, carbon-disk working electrode, 0.95 V (relative to Ag/AgCl) as detection potential, and sample injection for 8 s at 17 kV. The linear ranges were from 1.25 to 50 μg mL−1 for L-dopa, 1.2 × 10−1 to 25.5 μg mL−1 for BS, and 1.0 × 10−2 to 4.4 × 10−1 μg mL−1 for Ro-04-1419, with correlation coefficients of 0.9994, 0.9951, and 0.9933, respectively. The detection limits for L-dopa, BS, and Ro-04-1419 were 0.38, 0.02, and 0.004 μg mL−1, respectively. Average recoveries were 100.2% for L-dopa, 102.4% for BS, and 90.8% for Ro-04-1419. This method was successfully applied to co-beneldopa granules and tablets.

Keywords

Capillary electrophoresis Amperometric detection Levodopa Benserazide and (R,S)-2-amino-3-hydroxypropanohydrazide Co-beneldopa pharmaceutical formulations 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Calne DB, Sandler M (1970) Nature 226:21–24Google Scholar
  2. British Pharmaceutical Codex (1973) The Pharmaceutical Press, BloomsburyGoogle Scholar
  3. Ghose K (1985) Drugs Today 10:463–471Google Scholar
  4. Sweetman SC (ed) (2002) Martindale—the complete drug reference, 33rd edn. Pharmaceutical Press, London, UK, p 1160Google Scholar
  5. State Food and Drug Administration of P.R. China (1999) JX 19990140: Import specification of co-beneldopa granules, China, pp 581–582Google Scholar
  6. British Pharmacopoeia (2004) Co-beneldopa capsules. Stationery Office, London, UK, pp 2303–2305Google Scholar
  7. British Pharmacopoeia (2004) Dispersible Co-beneldopa tablets. Stationery Office, London, UK, pp 2305–2306Google Scholar
  8. Fanali S, Pucci V, Sabbioni C, Reggi MA (2000) Electrophoresis 21:2432–2437Google Scholar
  9. Uslu B, Ozkan SA (2002) Anal Lett 35(2):303–314Google Scholar
  10. Coello J, Maspoch S, Villegas N (2000) Talanta 53:627–637Google Scholar
  11. Hassib ST (1990) Anal Lett 23:2195–2214Google Scholar
  12. Hassib ST, El-Khateeb SZ (1990) Anal Lett 23:255–271Google Scholar
  13. Fu CG, Song LN, Fang YZ (1999) Anal Chim Acta 399:259–263CrossRefGoogle Scholar
  14. You TY, Yang XR, Wang EK (1999) Anal Chim Acta 401:29–34Google Scholar
  15. Wang AF, Zhou Y, Wang F, He PG, Fang YZ (2004) J Pharm Biomed Anal 35:959–964Google Scholar
  16. Zhang L, Chen GN, Hu Q, Fang YZ (2001) Anal Chim Acta 431:287–292Google Scholar
  17. Zhou TS, Hu Q, Yu H, Fang YZ (2001) Anal Chim Acta 441:23–28Google Scholar
  18. Zhang LY, Qv SF, Wang ZL, Cheng JK (2003) J Chromatogr B 792:381–385Google Scholar
  19. Chu QC, Cao YH, Peng YY, Fu L, Ye JN (2004) Chromatographia 60:125–130Google Scholar
  20. Chen G, Luo HF, Ye JN, Hu CQ (2001) Talanta 54:1067–1076CrossRefGoogle Scholar
  21. Fang YZ, Fang XM, Ye JN (1995) Chem J Univ 16:1514–1517Google Scholar
  22. Fu CG, Song LN, Fang YZ (1998) Anal Chim Acta 37:181–187Google Scholar
  23. Zhou TS, Yu H, Hu Q, Fang YZ (2002) Pharm Biomed Anal 20:13–19Google Scholar
  24. Gomez R, Hagel RB, MacMullan EA (1976) Anal Profiles Drug Subs 5:189–223Google Scholar
  25. Schwartz DE, Brandt R (1978) Arzneimittelforschung 28:302–307Google Scholar
  26. United States Pharmacopeial Convention (2004) Validation of compendial methods. In: US Pharmacopoeia, 27th edn. The United States Pharmacopeial Convention, MD, USA, pp 2622–2625Google Scholar
  27. Hartmann C, Massart DL, McDowall RD (1994) J Pharm Biomed Anal 12(11):1337–1343Google Scholar

Copyright information

© Friedr. Vieweg&Sohn/GWV Fachverlage GmbH 2005

Authors and Affiliations

  • J. Wang
    • 1
    • 2
  • Y. Zhou
    • 1
  • J. Liang
    • 1
  • P.G. He
    • 1
  • Y.Z. Fang
    • 1
  1. 1.Department of ChemistryEast China Normal UniversityShanghaiP.R. China
  2. 2.Chemical Division IIShanghai Institute for Drug ControlShanghaiP.R. China

Personalised recommendations